Disclaimer: The following strategies are hypothetical and for educational purposes only. iSpecimen Inc. (ISPC) is a highly volatile, low-priced micro-cap stock. The provided "data" indicates no real-time options chain exists. Therefore, all strategies, strikes, expirations, and Greeks are simulated based on the technical and market context to demonstrate the application of quantitative principles. Trading such instruments carries extreme risk.
- Underlying: ISPC
- View: Cautiously Bullish / Oversold Bounce. Aiming for the price to stay above a key support level, capitalizing on high IV to collect premium.
- Strategy Type: Defined Risk, Credit, Bullish
- Option Contract Portfolio:
- Sell 1 ISPC Put @ $0.12 strike (Simulated)
- Buy 1 ISPC Put @ $0.10 strike (Simulated)
- Expiration: 30-45 days out (e.g., June 2026)
- Max Gain & Loss:
- Max Gain: Net Credit Received
- Max Loss: ($0.12 - $0.10) - Net Credit
- Initial Cost/Credit: Net Credit (e.g., ~$0.008 per share)
- Greek Exposure (Simulated):
- Delta: +0.25 to +0.35 (Positive, directional bullish)
- Theta: +0.015 (Positive, benefits from time decay)
- Vega: -0.010 (Negative, hurts if IV rises, but benefits from selling high IV)
- Gamma: -0.08 (Negative, small, as short options are closer to ATM)
- Rho: Low (Negligible for short-dated, low-priced options)
- Rationale: This strategy aligns with a "cautiously bullish" view expecting the price to hold above $0.11 support. Selling the $0.12 put collects premium due to the high IV and defined high volume range ($0.11-$0.20). The long $0.10 put defines and limits risk below the key $0.11 support. The strategy has a positive Theta, generating income from time decay, and a slightly positive Delta for directional upside. The negative Vega is acceptable as we are selling elevated IV, expecting it to normalize or the stock to rise.
- Time Frame: Short-Term (30-45 days)
Follow me to learn more about analysis!!
Comments